Methylenetetrahydrofolate reductase (MTHFR): Incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida

American Journal of Medical Genetics

Volumn 119 A, Issue 1, 2003, Pages 20-25

  Alvarez Perez, Ana Beatriz ^a   D'Almeida, Vânia ^a   Vergani, Naja ^a   De Oliveira, Allan C ^a   De Lima, Fernanda Teresa ^a   Brunoni, Decio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Folic acid; Homo cysteine; MTHFR; Neural tube defects; Polymorphism; Spina bifida

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTINE; HOMOCYSTEINE; METHIONINE;

ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLATE METABOLISM; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; RISK FACTOR; SPINA BIFIDA;

BRAZIL; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; HOMOCYSTEINE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POINT MUTATION; SPINAL DYSRAPHISM;

HOMO;

EID: 0041320771     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. 1997. The mutation Ala677 → Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis. Thromb Hemost 77:818-821.
2. Arruda VR, Siqueira LH, Gonçalves MS, von Zuben PM, Soares MCP, Menezes R, Annichino-Bizzacchi JM, Costa FF. 1998. Prevalence of the mutation C677 → T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78:332-335.
3. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGe review. Am J Epidemiol 151:862-877.
4. Brunoni D. 1986. Alto risco genético. Aspectos neonatais. Pediatria Moderna XXI(8):415-417.
5. Castilla EE, Orioli IM. 1985. Epidemiology of neural tube defects in South America. Am J Med Genet 22:695-702.
6. Centers for Disease Control and Prevention (CDCP). 1993. Recommendations for use of folic acid to reduce number of spina bifida cases and other neural tubes defects. JAMA 269:1233-1238.
7. Cunha ALA, Hirata M, Kim CA, Guerra-Shinohara EM, Nonoyama K, Hirata RDC. 2002. Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with neural tube defects. Clinica Chimica Acta 318:139-143.
8. Czeizel AE, Dudás I. 1992. Prevention of the first occurrence of neural-tube defects by periconcepcional vitamin supplementation. N Engl J Med 327:1832-1835.
9. de Franchis R, Buoniconti A, Mandato C, Pepe A, Sperandeo MP, Del Gado R, Capra V, Salvaggio E, Andria G, Mastrioacovo P. 1988. The C677T mutation of the 5,10-methylenetetrayidrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 35:1009-1013.
10. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan KM, Fagan RF, Arner TG. 1994. Epi Info, version 6: A word processing, database, and statistics program for epidemiology on microcomputers. Atlanta: Center for Disease Control and Prevention.
11. Eskes TKAB. 1997. Folates and the fetus. Eur J Obstet Gynecol Reprod Biol 71:105-111.
12. Franco RF, Araújo AG, Guerreiro JF, Elion J, Zago MA. 1998. Analysis of the 677C → T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups. Thromb Haemost 79:119-121.
13. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, Der Heijer M, Kluitmans LAJ, Van der Heuvel LP, Rozen R. 1995. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
14. Gaspar DA, Pavanello RC, Zatz M, Passos-Bueno MR, André M, Steman S, Wyszynski DF, Matiolli SR. 1999. Role of the C677T polymorphism at the MTHFR gene on risk to nonsyndromic cleft lip with/without cleft palate: Results from a case-control study in Brazil. Am J Med Genet 87:197-199.
15. Goyette P, Summer JS, Milos R, Duncan AMV, Rosenblatt DS, Matthews RG, Rozen R. 1994. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping, and mutation identification. Nat Genet 7:195-200.
16. Goyette P, Frosst P, Rosenblatt DS, Rozen R. 1995. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 56:1052-1059.
17. Isotalo PA, Wells GA, Donnelly JG. 2000. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymosphisms: An examination of C677T and A1298C mutations. Am J Hum Genet 67: (online).
18. Kang S, Wong PKW, Bock HO, Hoewitz A, Grix A. 1991. Intermediate homocysteinemia resulting from compound heterozygosity for methylenetetrahydrofolate reductase mutations. Am J Hum Genet 48:546-551.
19. Koch MC, Stegmann K, Ziegler A, Schöter xx, Ermert A. 1998. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157:487-492.
20. Miller AS, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
21. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. 1995. Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345:149-151.
22. Mornet E, Muller F, Lenvoise A. 1997. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100:512-514.
23. Papapetrou C, Lynch SA, Burn J, Edwards YH. 1996. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:58.
24. Pfeiffer CM, HuffDL, Gunter EW. 1999. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45:290-292.
25. Rady PL, Tyring SK, Hudnall D, Vargas T, Kellner LH, Nitowsky H, Matalon RK. 1999. Methylenetetrahydrofolate reductase (MTHFR): The incidence of mutations C677T e A1298C in the Ashkenazi Jewish population. Am J Med Genet 86:380-384.
26. Rozen R. 1996. Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid. Clin Invest Med 19(3):171-178.
27. Selhub J. 1999. Homocysteine metabolism. Ann Rev Nutr 19:217-246.
28. Shields DC, Kirke PN, Mills JL. 1999. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-1055.
29. Speer MC, Nye J, McLone D, Worley G, Melvin EC, Viles KD, Franklin A, Drake C, Mackey JI, George TM. 1999. Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. NTD Collaborative Group. Clin Genet 56:142-144.
30. Stegmann K, Ziegler A, Ngo ETK, Kohlschmidt N, Schröter B, Ermert A, Koch MC. 1999. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 87:23-29.
31. Trembath D, Sherbondy AL, Vandike DC. 1999. Analysis of select folate pathway genes, PAX3, and human T in a midwestern neural tube defect population. Teratology 59:331-341.
32. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, Van der Heuvel LP, Mariman ECM, Den Heyer M, Rozen R, Blom HJ. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 356:1070-1071.
33. Van der Put NMJ, Gabreëls F, Stevens BEM, Smeitink JAM, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Blom HJ. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051.
34. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 88:763-766.
35. WHO. 1993. Hereditary Diseases Programme: Guidelines for the development of national programmes for monitoring birth defects. pp 11-12. WHO/HDP/ICBDMS/GL/93.4 (54pp).